ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 135 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 2.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $230,000 | +360.0% | 12,198 | +183.1% | 0.00% | – |
Q2 2019 | $50,000 | -86.7% | 4,309 | -84.4% | 0.00% | -100.0% |
Q1 2019 | $377,000 | +9325.0% | 27,663 | +5913.7% | 0.00% | – |
Q4 2018 | $4,000 | -97.1% | 460 | -94.5% | 0.00% | – |
Q3 2018 | $140,000 | -29.6% | 8,409 | -33.3% | 0.00% | -100.0% |
Q2 2018 | $199,000 | +114.0% | 12,614 | +55.2% | 0.00% | -75.0% |
Q4 2017 | $93,000 | +63.2% | 8,126 | +74.3% | 0.00% | +100.0% |
Q3 2017 | $57,000 | -83.6% | 4,661 | -84.7% | 0.00% | -86.7% |
Q2 2017 | $347,000 | +1234.6% | 30,369 | +2298.8% | 0.02% | +1400.0% |
Q1 2017 | $26,000 | – | 1,266 | +4265.5% | 0.00% | – |
Q4 2016 | $0 | -100.0% | 29 | -90.2% | 0.00% | – |
Q2 2016 | $7,000 | -97.9% | 296 | -97.8% | 0.00% | -100.0% |
Q1 2016 | $332,000 | +219.2% | 13,564 | +329.2% | 0.03% | +225.0% |
Q4 2015 | $104,000 | -86.4% | 3,160 | -86.5% | 0.01% | -85.7% |
Q3 2015 | $764,000 | +594.5% | 23,346 | +1023.5% | 0.06% | +522.2% |
Q2 2015 | $110,000 | – | 2,078 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |